Sex-specific maladaptive responses to acute stress upon in utero THC exposure are mediated by dopamine

Publication date

2026-02-13T12:28:20Z

2026-02-13T12:28:20Z

2024

2026-02-13T12:28:19Z



Abstract

Cannabis remains by far the most consumed illicit drug in Europe. The availability of more potent cannabis has raised concerns regarding the enhanced health risks associated with its use, particularly among pregnant women. Growing evidence shows that cannabis use during pregnancy increases the risks of child psychopathology. We have previously shown that only male rat offspring prenatally exposed to Δ9-tetrahydrocannabinol (THC), a rat model of prenatal cannabinoid exposure (PCE), display a hyperdopaminergic phenotype associated with a differential susceptibility to acute THC- and stress-mediated effects on sensorimotor gating functions. Here, we explore the contribution of the hypothalamic-pituitary-adrenal (HPA) axis, key regulator of body adaptive stress responses, to the detrimental effects of acute stress on ventral tegmental area (VTA) dopamine neurons and sensorimotor gating function of PCE rats. We report a sex-dependent compromised balance in mRNA levels of genes encoding mineralocorticoid and glucocorticoid receptors in the VTA, alongside with stress-induced pre-pulse inhibition (PPI) impairment. Notably, VTA dopamine neuronal activity is causally linked to the manifestation of stress-dependent deterioration of PPI. Finally, pharmacological manipulations targeting glycogen-synthase-kinase-3-β signaling during postnatal development correct these stress-induced, sex-specific and dopamine-dependent disruption of PPI. Collectively, these results highlight the critical sex-dependent interplay between HPA axis and dopamine system in the regulation of sensorimotor gating functions in rats.


The present study was funded by the Horizon Europe 2022 Excellent Science - European Research Council (101088207 to M.M.). A.B-G. and L.P-V. received funding from the DIUE de la Generalitat de Catalunya (SGR 00022, 2023 Fl-3 00034) and from the H2020 Excellent Science - European Research Council (948217 to A.B-G.).

Document Type

Article


Published version

Language

English

Publisher

Elsevier

Related items

Pharmacological Research. 2024;210:107536

info:eu-repo/grantAgreement/EC/HE/101088207

info:eu-repo/grantAgreement/EC/H2020/948217

Recommended citation

This citation was generated automatically.

Rights

© 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

http://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)